By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Iwilfin
Drugs

Iwilfin

https://themeditary.com/drug/iwilfin-23221.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Apr 10, 2024  Additional Content by TheMediTary.Com

Generic name: Eflornithine

Pregnancy & Lactation: Risk data not available

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Iwilfin?

Eflornithine is used in adults and children to keep high-risk neuroblastoma (HRNB), a certain type of cancer, from coming back.

Eflornithine is given after prior treatments partially worked.

Eflornithine may also be used for purposes not listed in this medication guide.

Warnings

Tell your doctor if you have ever had:

  • hearing problems; or
  • low blood cell counts.

Eflornithine can harm an unborn baby if the mother or the father is using this medicine.

  • If you are a woman, you may need a pregnancy test to make sure you are not pregnant. Use birth control while using this medicine and for at least 1 week after your last dose.
  • If you are a man, use birth control if your sex partner is able to get pregnant. Keep using birth control for at least 1 week after your last dose.
  • Tell your doctor right away if a pregnancy occurs.

Do not breastfeed while using this medicine, and for at least 1 week after your last dose.

How should I use Iwilfin

Use Iwilfin (Oral) exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.

Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

Your doctor will perform tests to make sure eflornithine is the right treatment for you.

Eflornithine is usually taken twice per day, with or without food. Your doctor will determine the right treatment schedule for you.

Swallow the tablet whole. If you cannot swallow a tablet whole, eflornithine can be chewed, or crushed then mixed with soft food or liquid.

Read and carefully follow the instructions provided to you on how to prepare and take eflornithine if you are unable to swallow the medicine. Ask your doctor or pharmacist if you don't understand these instructions.

Doses are based on body surface area (height and weight). Your dose may change if you gain or lose weight or if you are still growing.

You will need frequent medical tests before starting and during treatment, including hearing tests. Your next dose may change or be delayed based on the results.

If you vomit shortly after taking eflornithine, do not take another dose. Take your next dose as scheduled.

Store at room temperature away from moisture and heat.

What should I do if I missed a dose of Iwilfin (Oral)?

Take the medicine as soon as you can, but skip the missed dose if your next dose is due within 7 hours. Do not use two doses at one time.

Iwilfin side effects

Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • hearing problems such as ringing in your ears or hearing loss;
  • liver problems--loss of appetite, nausea, vomiting, stomach pain (upper right side), tiredness, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
  • low blood cell counts--fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.

Your cancer treatments may change, be delayed, or permanently discontinued if you have certain side effects.

Common side effects may include:

  • fever, diarrhea, vomiting;
  • ear, sinus, or skin infections;
  • pneumonia;
  • urinary infection (UTI);
  • cold or allergy symptoms such as cough, stuffy, runny, or itchy nose, sneezing, sore throat; or
  • red or swollen eyes (pinkeye).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Iwilfin?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

More about Iwilfin (Eflornithine)

Drug images
Side effects
Drug class: Drugs
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by